In Setback For Glaxo, European Court Clears Paxil Generics

Law360, New York (January 20, 2005, 12:00 AM EST) -- In a blow to U.K. drug maker GlaxoSmithKline PLC, the European Court of Justice has ruled that generic drug makers should be allowed to market versions of its top-selling anti-depressant Seroxat, marketed in the U.S. as Paxil.

The appeals court upheld a ruling by Danish authorities to approve generic drugs based on the active ingredients in Paxil, known in Europe as Seroxat.

Glaxo had appealed the Danish ruling, arguing that the generic drug makers were using "a different salt form" of Paxil's active ingredient and should...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.